JP2010022359A - タヒボ、シャンピニオン及び桑の葉を主原料にした健康食品組成物 - Google Patents
タヒボ、シャンピニオン及び桑の葉を主原料にした健康食品組成物 Download PDFInfo
- Publication number
- JP2010022359A JP2010022359A JP2009010890A JP2009010890A JP2010022359A JP 2010022359 A JP2010022359 A JP 2010022359A JP 2009010890 A JP2009010890 A JP 2009010890A JP 2009010890 A JP2009010890 A JP 2009010890A JP 2010022359 A JP2010022359 A JP 2010022359A
- Authority
- JP
- Japan
- Prior art keywords
- group
- champignon
- powder
- mulberry leaf
- tahibo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 71
- 244000251953 Agaricus brunnescens Species 0.000 title claims abstract description 70
- 240000000249 Morus alba Species 0.000 title claims abstract description 55
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 239000010233 Taheebo Substances 0.000 title abstract description 4
- 235000001497 healthy food Nutrition 0.000 title abstract 3
- 239000002994 raw material Substances 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 41
- 235000013402 health food Nutrition 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 5
- 240000000111 Saccharum officinarum Species 0.000 claims description 5
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 5
- 239000002361 compost Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 3
- 238000009264 composting Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 239000011777 magnesium Substances 0.000 description 8
- 229910052749 magnesium Inorganic materials 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 229910021529 ammonia Inorganic materials 0.000 description 7
- 239000004202 carbamide Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 229910052802 copper Inorganic materials 0.000 description 6
- 239000010949 copper Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 229910052793 cadmium Inorganic materials 0.000 description 5
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 3
- 235000019645 odor Nutrition 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019737 Animal fat Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【解決手段】タヒボ粉末20〜50重量部とシャンピニオン粉末20〜50重量部及び桑の葉粉末20〜50重量部を配合して製造される。
【選択図】図1
Description
1970年代後半から所得向上に伴って食生活が西欧化されながら肉食が急速に増えながら、その間菜食を主にして来た過去にはあまりなかった各種成人病が急激に増加して、これらは社会問題にまで頭をもたげるようになった。すなわち、動物性脂肪食品や加工食品、インスタント食品及び各種食品添加物の摂取量が急増したので、腸内環境が悪くなるようになり、その結果平均寿命が大きく増えたにもかかわらず、人間本来の免疫力が低下して肥満、高血圧、糖尿、高脂血症など各種疾病にかかりやすくなった。
その結果、食生活に対する反省と共に健康に対する関心がいつより高くなり、これによって成人病を予防することができる健康食品に対する要求も大きく増えている。
前記堆肥にシャンピニオン菌を注入して30〜50日間培養する段階;
前記培養されたシャンピニオンを採取して水で洗滌した後2〜5cm大きさで切断する段階;
前記大きさで切断したシャンピニオンを乾燥器に移送して、45〜55℃に8〜12時間乾燥させる段階;及び
前記乾燥したシャンピニオンを粉砕機に移送して、1.5mmの粉末に粉碎する段階;を経って製造されたことを特徴とする。
2-1.ルミノール測定結果
縦軸に測定した発光強度を示して、投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の血清においてのペルオキシラディカル(Peroxy Radical)に対するスカベンジング(Scarvenging)作用の結果を図1に示した。
図1で見るところのように、Control群の発光強度と比べて桑の葉群、タヒボ群、シャンピニオン群、特に配合群の発光強度減少が著しかった。したがって、すべての投与群、特に配合群にペルオキシラディカルスカベンジング作用を期待することができることが分かる。
縦軸に測定したSOD活性度(%)を示して、投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の血清においてのラディカルに対する抗酸化作用の結果を図2に示した。
図2で見るところのように、Control群のSOD活性度と比べて桑の葉群、タヒボ群、シャンピニオン群、特に配合群のSOD活性度増加が著しかった。したがって、すべての投与群に対する抗酸化作用を期待することができるし、特に配合群には抗酸化作用に相乗効果があることが分かる。
2-3-1.血中の尿素濃度
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の血中の尿素濃度の結果を図3に示した。
図3で見るところのようにControl群と比べて桑の葉群、タヒボ群、シャンピニオン群の血中の尿素濃度低下が認められたし、特に配合群の血中の尿素濃度低下が著しかった。
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の血中の乳酸濃度の結果を図4に示した。
図4で見るところのようにControl群と比べて桑の葉群、タヒボ群、シャンピニオン群、配合群の血中の乳酸濃度の低下が認められた。
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の血中のアンモニア濃度の結果を図5に示した。
図5で見るところのようにControl群と比べて桑の葉群、タヒボ群、シャンピニオン群の血中のアンモニア濃度低下が認められたし、特に配合群の血中のアンモニア濃度低下が著しかった。
2-3-4-1.小便による銅の濃度
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の小便による銅の濃度の結果を図6に示した。
図6で見るところのようにControl群の小便中の銅の濃度と比べて桑の葉群、タヒボ群、シャンピニオン群では別に差がなかった。しかし、配合群では銅濃度の低下が認められた。
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の小便による鉛の濃度の結果を図7に示した。
図7で見るところのようにControl群の小便中の鉛の濃度と比べる時桑の葉群、タヒボ群、シャンピニオン群で低かったことを分かったし、特に配合群の場合鉛濃度が最も低かった。
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の小便による亜鉛の濃度の結果を図8に示した。
図8で見るところのようにControl群の小便中の亜鉛の濃度と比べる時桑の葉群、タヒボ群、シャンピニオン群で低かったことを分かったし、特に配合群の場合亜鉛濃度が最も低かった。
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の小便によるマグネシウムの濃度の結果を図9に示した。
図9で見るところのようにControl群の小便中のカドミウムの濃度と比べる時桑の葉群、タヒボ群、シャンピニオン群で低かったことを分かったし、特に配合群の場合カドミウム濃度が最も低かった。
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の小便によるマグネシウムの濃度の結果を図10に示した。
図10で見るところのようにControl群の小便中のマグネシウムの濃度と比べる時桑の葉群、タヒボ群で低かったことを分かったし、特にシャンピニオン群と配合群の場合マグネシウム濃度がさらに低かった。
投与60日後のControl群、桑の葉群、タヒボ群、シャンピニオン群及び配合群の小便によるナトリウムの濃度の結果を図11に示した。
図11で見るところのようにControl群の小便中のナトリウムの濃度と比べる時桑の葉群、タヒボ群では別に差がなかったが、シャンピニオン群の場合ナトリウム濃度が低かったし、配合群の場合ナトリウム濃度が最も低かった。
Claims (2)
- タヒボ粉末20〜50重量部とシャンピニオン粉末20〜50重量部及び桑の葉粉末20〜50重量部を配合して製造されたことを特徴とする健康食品組成物。
- 前記シャンピニオン粉末は、砂糖黍を搾った後残った残物または豆を搾った後残った残物を60〜90日間堆肥を生産する段階;
前記堆肥にシャンピニオン菌を注入して30〜50日間培養する段階;
前記培養されたシャンピニオンを採取して、水で洗滌した後2〜5cm大きさで切断する段階;
前記大きさで切断したシャンピニオンを乾燥器に移送して、45〜55℃で8〜12時間乾燥させる段階;及び
前記乾燥したシャンピニオンを粉砕機に移送して、1.5mmの粉末に粉碎する段階;を経って製造されたことを特徴とする請求項1に記載の健康食品組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080069867A KR101017556B1 (ko) | 2008-07-18 | 2008-07-18 | 타히보, 샴피니온 및 뽕잎을 주원료로 한 건강식품 조성물 |
KR10-2008-0069867 | 2008-07-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010022359A true JP2010022359A (ja) | 2010-02-04 |
JP4802251B2 JP4802251B2 (ja) | 2011-10-26 |
Family
ID=41728798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009010890A Expired - Fee Related JP4802251B2 (ja) | 2008-07-18 | 2009-01-21 | タヒボ、シャンピニオン及び桑の葉を主原料にした健康食品組成物 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4802251B2 (ja) |
KR (1) | KR101017556B1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102670769A (zh) * | 2011-03-18 | 2012-09-19 | 李启辉 | 一种纯天然植物配方降压茶及其制备方法 |
JP2014129249A (ja) * | 2012-12-28 | 2014-07-10 | Pola Chem Ind Inc | 毛髪用の皮膚外用剤 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10722548B2 (en) | 2017-07-14 | 2020-07-28 | Cosmax Nbt, Inc. | Method of preparing lyophilizate of Taheebo alcohol extract |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02150239A (ja) * | 1988-12-01 | 1990-06-08 | Shoichi Shimizu | タヒボ含有の菓子類 |
JPH09252746A (ja) * | 1996-03-22 | 1997-09-30 | Nippon Kankyo Yakuhin Kk | 栄養補助食品 |
JP2005034117A (ja) * | 2003-07-14 | 2005-02-10 | Hokkaido Ekotekkusu Kk | 食品残渣等廃棄物からリサイクルしたコンポスト(堆肥)の、茸の菌床(培地)栽培への利用技術と方法。 |
JP2007330124A (ja) * | 2006-06-13 | 2007-12-27 | Kenko Tsusho Kk | 肥満及び生活習慣病の防止・改善をする為の健康食品用組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080092263A (ko) * | 2007-04-10 | 2008-10-15 | 김국현 | COX-2 및 iNOS 단백질 발현 저해제 |
-
2008
- 2008-07-18 KR KR1020080069867A patent/KR101017556B1/ko not_active IP Right Cessation
-
2009
- 2009-01-21 JP JP2009010890A patent/JP4802251B2/ja not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02150239A (ja) * | 1988-12-01 | 1990-06-08 | Shoichi Shimizu | タヒボ含有の菓子類 |
JPH09252746A (ja) * | 1996-03-22 | 1997-09-30 | Nippon Kankyo Yakuhin Kk | 栄養補助食品 |
JP2005034117A (ja) * | 2003-07-14 | 2005-02-10 | Hokkaido Ekotekkusu Kk | 食品残渣等廃棄物からリサイクルしたコンポスト(堆肥)の、茸の菌床(培地)栽培への利用技術と方法。 |
JP2007330124A (ja) * | 2006-06-13 | 2007-12-27 | Kenko Tsusho Kk | 肥満及び生活習慣病の防止・改善をする為の健康食品用組成物 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102670769A (zh) * | 2011-03-18 | 2012-09-19 | 李启辉 | 一种纯天然植物配方降压茶及其制备方法 |
JP2014129249A (ja) * | 2012-12-28 | 2014-07-10 | Pola Chem Ind Inc | 毛髪用の皮膚外用剤 |
Also Published As
Publication number | Publication date |
---|---|
KR20100009136A (ko) | 2010-01-27 |
JP4802251B2 (ja) | 2011-10-26 |
KR101017556B1 (ko) | 2011-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6185157B2 (ja) | 多機能組成物並びにその作製方法及び使用 | |
KR101357338B1 (ko) | 육질개선용 사슴사료 조성물 및 그 사료를 급여한 사슴으로부터 얻어지는 사포닌, 유황, 불포화지방산 함량이 높은 사슴육과 녹용 | |
KR101956516B1 (ko) | 닭사료 조성물 및 그 제조방법 | |
JP4802251B2 (ja) | タヒボ、シャンピニオン及び桑の葉を主原料にした健康食品組成物 | |
KR101745424B1 (ko) | 천연 dha 강화 섬유질 완전 혼합 사료 조성물 | |
KR101895733B1 (ko) | 반려동물용 혼합사료 | |
CN109315348B (zh) | 一种麻香猪的养殖方法 | |
KR101902313B1 (ko) | 반려동물 전용 이유식 및 영양식 조성물 | |
JP2011037811A (ja) | 脂肪低減用組成物 | |
CN110651895B (zh) | 一种解决宠物泪痕的功能性食品及其制备方法 | |
KR100902406B1 (ko) | 장어양식용 사료 | |
KR100937552B1 (ko) | 쑥을 이용한 사료 첨가제 및 그 제조방법 | |
KR20060089201A (ko) | 뽕잎을 투입한 축산방법 | |
CN106819575A (zh) | 一种抗肉鸡热应激的饲料配方 | |
CN109010166B (zh) | 一种植物源小分子口腔清洁剂及其制备方法 | |
KR20110014418A (ko) | 당뇨환자의 혈당조절용 고추장 | |
CN106306528A (zh) | 一种提高产蛋率鸡饲料添加剂 | |
KR20210087284A (ko) | 유황오리 사육용 천연식물유황사료 제조방법 | |
KR20120080793A (ko) | 밤을 유효성분으로 포함하는 사료 조성물 및 이의 제조방법 | |
CN111820342B (zh) | (2-羧乙基)二甲基溴化锍在制备增强草鱼皮肤屏障功能的混合物中的应用 | |
KR101398887B1 (ko) | 알팔파와 페닐락트산 함유 분말건조물을 포함하는 사료첨가제 조성물 및 상기 사료 첨가제 급여에 의한 계란의 생산방법 | |
CN108567059B (zh) | 一种猪饲料及其制备方法 | |
CN107087728A (zh) | 一种饲料添加剂及制备方法 | |
KR20230129284A (ko) | 발효 상황버섯을 포함하는 동물 사료용 조성물 및 이의 제조방법 | |
KR101554844B1 (ko) | 콩 쥐치포 및 그 생산 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090313 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100922 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101005 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101221 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110322 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110509 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110502 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110602 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110628 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110701 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110726 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110808 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140812 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4802251 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |